Syndrome of Cocaine-Levamisole-Induced Cutaneous Vasculitis and Immune-Mediated Leukopenia

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 3, 2011, Pages 434-444

  Poon, Samuel H ^a   Baliog, Crisostomo R ^a   Sams, Ralph N ^a   Robinson Bostom, Leslie ^a   Telang, Gladys H ^a   Reginato, Anthony M ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Cocaine; Cutaneous vasculitis; Levamisole; Neutropenia; Pseudovasculitis

Indexed keywords

ANTIBIOTIC AGENT; COCAINE; COLCHICINE; CORTICOSTEROID; IBUPROFEN; IMMUNOGLOBULIN M ANTIBODY; LEVAMISOLE; NAPROXEN; NEUTROPHIL CYTOPLASMIC ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; ANTIBODY TITER; ARTHRALGIA; ARTHRITIS; ARTICLE; CASE REPORT; COCAINE LEVAMISOLE INDUCED CUTANEOUS VASCULITIS SYNDROME; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE MEDIATED LEUKOPENIA; LEUKOPENIA; MALE; NEUTROPENIA; PRIORITY JOURNAL; PURPURA; SKIN ULCER; STOMATITIS; VASCULITIS;

ANTIRHEUMATIC AGENTS; COCAINE; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; LEUKOPENIA; LEVAMISOLE; MALE; MIDDLE AGED; PURPURA; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS;

EID: 84860389306     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.05.009     Document Type: Article

References (37)

1. Brewer J.D., Meves A., Bostwick J.M., Hamacher K.L., Pittelkow M.R. Cocaine abuse: dermatologic manifestations and therapeutic approaches. J Am Acad Dermatol 2008, 59:483-487.
2. Agranulocytosis associated with cocaine use-four States, March 2008-November 2009. MMWR Morb Mortal Wkly Rep 2009, 58:1381-1385. Centers for Disease Control and Prevention (CDC).
3. Knowles L., Buxton J.A., Skuridina N., Achebe I., LeGatt D., Fan S., et al. Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduction J 2009, 6:1-7.
4. Martin R.J., Verma S., Levandoski M., Clark C.L., Qian H., Stewart M., et al. Drug resistance and neurotransmitter receptors of nematodes: recent studies on the mode of action of levamisole. Parasitology 2005, 131(Suppl):S71-S84.
5. Laurie J.A., Moertel C.G., Fleming T.R., Wieland H.S., Leigh J.E., Rubin J. Surgical adjuvant therapy of large-bowel carcinoma: An evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 1989, 7:1447-1456.
6. Moertel C.G., Fleming T.R., Macdonald J.S., Haller D.G., Laurie J.A., Goodman P.J. Levamisole and Fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990, 322:352-358.
7. Veys E.M., Mielants H., Verbruggen G. Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis-a long-term follow-up study. Clin Exp Rheumatol 1987, 5:111-116.
8. Albonico M., Bickle Q., Ramsan M., Montresor A., Savioli L., Taylor M. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull World Health Organ 2003, 81:343-352.
9. Thompson J.S., Herbick J.M., Klassen L.W., Severson C.D., Overlin V.L., Blaschke J.W., et al. Studies on levamisole-induced agranulocytosis. Blood 1980, 56:388-396.
10. Vogel C.L., Silverman M.A., Mansell P.W., Miller A.M., Thompson J.S., Herbick J.M., et al. Mechanisms of levamisole-induced granulocytopenia in breast cancer patients. Am J Hematol 1980, 9:171-183.
11. Barbano G., Ginevri F., Ghiggeri G.M., Gusmano R. Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome. Pediatr Nephrol 1999, 13:602-603.
12. Laux-End R., Inaebnit D., Gerber H.A., Bianchetti M.G. Vasculitis associated with levamisole and circulating autoantibodies. Arch Dis Child 1996, 75:355-356.
13. Menni S., Pistritto G., Gianotti R., Ghio L., Edefonti A. Ear lobe bilateral necrosis by levamisole-induced occlusive vasculitis in a pediatric patient. Pediatr Dermatol 1997, 14:477-479.
14. Rongioletti F., Ghio L., Ginevri F., Bleidl D., Rinaldi S., Edefonti A., et al. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 1999, 140:948-951.
15. Bagga A., Hari P. Levamisole-induced vasculitis. Pediatr Nephrol 2000, 14:1057-1058.
16. Molloy E.S., Langford C.A. Vasculitis mimics. Curr Opin Rheumatol 2008, 20:29-34.
17. Merkel P.A., Koroshetz W.J., Irizarry M.C., Cudkowicz M.E. Cocaine-associated cerebral vasculitis. Semin Arthritis Rheum 1995, 25:172-183.
18. Balbir-Gurman A., Braun-Moscovici Y., Nahir A.M. Cocaine induced Raynaud's phenomenon and ischaemic finger necrosis. Clin Rheumatol 2001, 20:376-378.
19. Orriols R., Muñoz X., Ferrer J., Huget P., Morell F. Cocaine-induced Churg-Strauss vasculitis. Eur Respir J 1996, 9:175-177.
20. Wiesner O., Russell K.A., Lee A.S., Jenne D.E., Trimarchi M., Gregorini G., et al. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum 2004, 50:2954-2965.
21. Enríquez R., Palacios F.O., González C.M., Amoros F.A., Cabezuelo J.B., Hernández F. Skin vasculitis, hypokalemia and acute renal failure in rhabdomyolysis associated with cocaine. Nephron 1991, 59:336-337.
22. Marder V.J., Mellinghoff I.K. Cocaine and Buerger disease: is there a pathogenetic association?. Arch Intern Med 2000, 160:2057-2060.
23. Dhawan S.S., Wang B.W. Four-extremity gangrene associated with crack cocaine abuse. Ann Emerg Med 2007, 49:186-189.
24. Chen S.C., Jang M.Y., Wang C.S., Tsai K.B., Chuang S.H., Chen H.C., et al. Cocaine-related vasculitis causing scrotal gangrene. Ann Pharmacother 2009, 43:375-378.
25. Bhinder S.K., Majithia V. Cocaine use and its rheumatic manifestations: a case report and discussion. Clin Rheumatol 2007, 26:1192-1194.
26. Daggett R.B., Haghighi P., Terkeltaub R.A. Nasal cocaine abuse causing an aggressive midline intranasal and pharyngeal destructive process mimicking midline reticulosis and limited Wegener's granulomatosis. J Rheumatol 1990, 17:838-840.
27. Friedman D.R., Wolfsthal S.D. Cocaine-induced pseudovasculitis. Mayo Clin Proc 2005, 80:671-673.
28. Bradford M., Rosenberg B., Moreno J., Dumyati G. Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med 2010, 152:758-759.
29. Waller J.M., Feramisco J.D., Alberta-Wszolek L., McCalmont T.H., Fox L.P. Cocaine-associated retiform purpura and neutropenia: Is levamisole the culprit?. J Am Acad Dermatol 2010, (63):530-535.
30. DeRemee R.A., McDonald T.J., Weiland L.H. Wegener's granulomatosis: observations on treatment with antimicrobial agents. Mayo Clin Proc 1985, 60:27-32.
31. Rasmussen N. Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist's perspective. Curr Opin Rheumatol 2001, 13:3-11.
32. Hofbauer G.F.L., Hafner J., Trueb R.M. Urticarial vasculitis following cocaine use. Br J Dermatol 1999, 141:573-609.
33. Geller L., Whang T.B., Mercer S.E., Phelps R. Retiform purpura: A new stigmata of illicit drug use?. Dermatol Online J 2011, 17:7.
34. Walsh N.M.G., Green P.J., Burlingame R.W., Pasternak S., Hanly J.G. Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole. J Cutan Pathol 2010, 37:1212-1219.
35. Fthenakis B.A., Klein P.A. Retiform purpura in a patient with a history of cocaine use. Dermatol Online J 2011, 17:12.
36. Van Wieren A., Kapoor M., Rao P., Gardner R. A new low for an old high: neutropenia induced by levamisole-adulterated cocaine. Med Health RI 2010, 93(10):320-321.
37. Farhat E.K., Muirhead T.T., Chaffins M.L., Douglas M.C. Levamisole-Induced Cutaneous Necrosis Mimicking Coagulopathy. Arch Dermatol 2010, 146:1320-1321.